Expert Review

DOI: 10.4244/EIJ-D-24-00535

Catheter-based techniques for pulmonary embolism treatment

Francesco Costa1,2, MD, PhD; Pablo Salinas3, MD, PhD; Mario Iannaccone4, MD; Enrico Cerrato5,6, MD, PhD; Daniel Tébar Márquez7, MD; Shantum Misra8,9, MD; Felix Götzinger10,11, MD; Gabriele Carciotto2, MD; Salvatore Silipigni2, MD; Victor Manuel Becerra-Muñoz1, MD, PhD; Marco Mennuni12, MD; Alberto Stagno2, MD; Antonio Bottari2, MD; Marco Pavani5,6, MD; Ferdinando Varbella5,6, MD; Juan Horacio Alonso-Briales1, MD; Alfonso Jurado-Román7, MD, PhD; Eric A. Secemsky8,9, MD, PhD; Felix Mahfoud10,12, MD, PhD; Antonio Micari2, MD, PhD

Abstract

Pulmonary embolism (PE) is a life-threatening condition characterised by occlusion of the pulmonary vasculature, with a global incidence of approximately 1 in 1,000 patients. While pharmacological therapy remains the cornerstone of PE management, selected patients may benefit from catheter-directed treatments due to their potential for rapid symptom relief and swift haemodynamic stabilisation. Catheter-directed thrombolysis and catheter-directed mechanical thrombectomy are current treatment options, though their availability is still limited. This review provides a practical outlook on catheter-directed therapies for PE, outlining optimal procedural planning, device selection, technical execution, evaluation of results, and management of complications.

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 9
May 5, 2025
Volume 21 Number 9
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00022 Sep 15, 2025
An ongoing quest to discern the optimal antithrombotic therapy after TAVI
Hayashida K and Iwata J
free

Research Correspondence

10.4244/EIJ-D-25-00255 Sep 15, 2025
Redo-TAVI with the ACURATE platform for failure of short-frame transcatheter heart valves
Tarantini G et al

Editorial

10.4244/EIJ-E-25-00038 Sep 15, 2025
Evolving cutoff values for optimising left main stenting with intravascular imaging
de la Torre Hernandez J
free

Original Research

10.4244/EIJ-D-24-01066 Sep 15, 2025
VARC-HBR criteria validation in TAVI patients on oral anticoagulation
Overduin D et al

Translational research

10.4244/EIJ-D-24-01000 Sep 15, 2025
DurAVR – a novel biomimetic balloon-expandable transcatheter valve for TAVI, valve-in-valve TAVI and redo-TAVI
Meier D et al
open access

Flashlight

10.4244/EIJ-D-25-00121 Sep 15, 2025
Calcium mapping by 3DStent technology
Amabile N and Benamer H

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
Trending articles
95.7

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
65.05

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
35.45

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved